Mortality and cancer in pediatric-onset inflammatory bowel disease: A population-based study

Keyphrases

• Acute Leukemia 33%
• Age-standardized Rate 33%
• Anti-tumor Necrosis Factor Therapy 33%
• Basal Cell Carcinoma 33%
• Biliary Tract 33%
• Cancer Colon 33%
• Cancer Registry 33%
• Cancer Risk 66%
• Cholangiocarcinoma 33%
• Cohort Mortality 33%
• Combination Therapy 33%
• Crohn's Disease 66%
• Disease Diagnosis 33%
• Disease Groups 33%
• Fisher's Exact Test 33%
• Follow-up Time 33%
• Inflammatory Bowel Disease 100%
• Lille 33%
• Mortality Rate 33%
• Neoplasia 33%
• Northern France 33%
• Pediatric Inflammatory Bowel Disease 33%
• Pediatric Onset 100%
• Pediatric Population 33%
• Population-based 33%
• Population-based Study 100%
• Prepuce 33%
• Risk of Death 33%
• Small Bowel Carcinoid 33%
• Standardized Incidence Ratio 66%
• Standardized Mortality Ratio 66%
• Ulcerative Colitis 66%
• Uterine Cervix 33%

Medicine and Dentistry

• Acute Leukemia 20%
• Basal-Cell Carcinoma 20%
• Cancer Registry 20%
• Carcinoid 20%
• Cholangiocarcinoma 20%
• Colon Carcinoma 20%
• Combination Therapy 20%
• Crohn's Disease 40%
• Fisher Exact Test 20%
• Hepatobiliary System 20%
• Immunosuppressant 20%
• Inflammatory Bowel Disease 100%
• Malignant Neoplasm 100%
• Mortality Rate 20%
• Neoplasm 20%
• Pediatrics 100%
• Prepuce 20%
• Standardized Incidence Ratio 40%
• Standardized Mortality Ratio 40%
• Tumor Necrosis Factor 20%
• Ulcerative Colitis 40%
• Uterine Cervix 20%